People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Other Health Care, Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| InterVene, Inc. | — | Other Health Care | Series A | $9.6M | $11.8M | 2015 |
| Sword Diagnostics Inc | — | Medical Devices | Seed | $3.4M | $45.2M | 2009 |
Mel Schatz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Mel Schatz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jay Schmelter | 1 | 6 |
| Evan Ng | 1 | 6 |
| Gail Page | 1 | 4 |
| Adam Berman | 1 | 4 |
| Catherine L. Matthes | 1 | 3 |
| Thomas Fogarty | 1 | 3 |
| Fletcher Wilson | 1 | 3 |
| Joe Biller | 1 | 3 |
| Michael Shepard | 1 | 2 |
| Joseph Falkenstein | 1 | 1 |
| David Dingott | 1 | 1 |
| Jeffrey Elkins | 1 | 1 |
| Sidney Braginsky | 1 | 1 |
| Edward Grogg | 1 | 1 |
| Ginger Glaser | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.